Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Murray Baron

Showing results (191-200 of 281) with videos related to

Pageof 29
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Early Mortality in a Multinational Systemic Sclerosis Inception CohortYanjie Hao, Marie Hudson, Murray Baron, et al.
Arthritis Care & Research|August 18, 2019
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?Laura Ross, Wendy Stevens, Michelle Wilson, et al.
Arthritis Care & Research|June 1, 2026
Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?Danick Goulet, Camille Guertin, Maggie Larché, et al.
Rheumatology (Oxford, England)|April 23, 2024
Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trialAndreu Fernández-Codina, Tatiana Nevskaya, Murray Baron, et al.
Autoimmunity|September 4, 2015
Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjectsMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Rheumatology (Oxford, England)|August 27, 2024
Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosisAndreu Fernández-Codina, Tatiana Nevskaya, Murray Baron, et al.
European Journal of Immunology|April 26, 2012
Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung diseaseMarianna M Newkirk, Simeon Mitchell, Michael Procino, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability IndexJessica L Fairley, Dylan Hansen, Murray Baron, et al.
Clinical and Experimental Rheumatology|August 17, 2024
The burden and determinants of fatigue in incident and prevalent systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease associationLydia Ouchene, Anastasiya Muntyanu, Deborah Assayag, et al.
Pageof 29

Showing results (191-200 of 281) with videos related to

Sort By:
Pageof 29
Arthritis & Rheumatology (Hoboken, N.J.)|December 29, 2016
Early Mortality in a Multinational Systemic Sclerosis Inception CohortYanjie Hao, Marie Hudson, Murray Baron, et al.
Arthritis Care & Research|August 18, 2019
Can Patient-Reported Symptoms Be Used to Measure Disease Activity in Systemic Sclerosis?Laura Ross, Wendy Stevens, Michelle Wilson, et al.
Arthritis Care & Research|June 1, 2026
Distinct Systemic Sclerosis Phenotypes Related to Ethnicity: An Opportunity to Personalize Care?Danick Goulet, Camille Guertin, Maggie Larché, et al.
Rheumatology (Oxford, England)|April 23, 2024
Brentuximab vedotin for skin involvement in refractory diffuse cutaneous systemic sclerosis, an open-label trialAndreu Fernández-Codina, Tatiana Nevskaya, Murray Baron, et al.
Autoimmunity|September 4, 2015
Clinical correlates of monospecific anti-PM75 and anti-PM100 antibodies in a tri-nation cohort of 1574 systemic sclerosis subjectsMichael Wodkowski, Marie Hudson, Susanna Proudman, et al.
Rheumatology (Oxford, England)|August 27, 2024
Brentuximab vedotin compared with historical controls for severe skin involvement in cutaneous systemic sclerosisAndreu Fernández-Codina, Tatiana Nevskaya, Murray Baron, et al.
European Journal of Immunology|April 26, 2012
Chronic smoke exposure induces rheumatoid factor and anti-heat shock protein 70 autoantibodies in susceptible mice and humans with lung diseaseMarianna M Newkirk, Simeon Mitchell, Michael Procino, et al.
Clinical and Experimental Rheumatology|August 17, 2024
Investigating the trajectory of functional disability in systemic sclerosis: group-based trajectory modelling of the Health Assessment Questionnaire-Disability IndexJessica L Fairley, Dylan Hansen, Murray Baron, et al.
Clinical and Experimental Rheumatology|August 17, 2024
The burden and determinants of fatigue in incident and prevalent systemic sclerosisJessica L Fairley, Dylan Hansen, Susanna Proudman, et al.
Journal of the American Academy of Dermatology|October 13, 2022
Skin disorders and interstitial lung disease: Part II-The spectrum of cutaneous diseases with lung disease associationLydia Ouchene, Anastasiya Muntyanu, Deborah Assayag, et al.
Pageof 29